Wells Fargo & Company Nutri Band Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Nutri Band Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 100 shares of NTRB stock, worth $515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 37
170.27%
Holding current value
$515
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NTRB
# of Institutions
20Shares Held
268KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA109KShares$563,2550.0% of portfolio
-
Geode Capital Management, LLC Boston, MA58.1KShares$299,0240.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny20.7KShares$106,7130.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$88,9190.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA16KShares$82,4720.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $40.2M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...